unisa logo

News and events

2019 2018 2017 2016 2015 2014 2013 2012



Investors inject 45 million into SA health and biotech industry

The Adelaide China Biotech Investment Fund is backed by a group of private investors based in Nanjing, China, underwritten by the Bank of Nanjing.


Ferronova cancer tracers ready for human trials

UniSA Ventures spin-out company Ferronova has produced its first tiny cancer tracers to help detect solid tumours, with human trials about to begin at the Royal Adelaide Hospital.


Malaysia’s top commercialisation influencer to steer UniSA Ventures

Named by the International Business Review Magazine as one of Malaysia’s top 60 economic influencers, Dr Viraj Perera has been appointed to lead UniSA Ventures, the University’s highly successful commercialisation operation. 


Dr Viraj Perera announced as new CEO

UniSA Ventures is pleased to announce that following an international search, Dr Viraj Perera has been appointed as our new CEO.


GSK puts Australian researchers on Discovery Fast Track

Professors Tom Gonda and Richard D’Andrea from the University of South Australia will work together with GSK scientists to test GSK compound libraries against a target protein that plays a role in a number of different cancers.


Groundbreaking female astronaut joins Myriota board

Myriota today announced that former NASA astronaut and ex-DARPA Deputy Director of the Tactical Technology Office, Pamela Melroy, has joined its board as a non-executive director.



SolarReserve teams with Heliostat SA

Companies form partnership to support manufacture of over 12,000 massive mirror assemblies in South Australia for the Aurora Solar Energy Project


UniSA wins funding for research into cancer, ageing, alcohol abuse and 3D bioprinting for medical use

The University of South Australia has been awarded more than $2.6 million in the latest round of Federal Government funding to further research into Australia’s most critical health issues.


Carina Biotech awarded $2.1m

Adelaide’s Carina Biotech has been awarded a $2.1 million Cooperative Research Centre Project (CRC-P) Program grant to continue its groundbreaking work developing new cell therapies to treat solid, pediatric and rare cancers.


Nanosatellite IoT startup Myriota closes US$15 million Series A round with global investors

Myriota, global leader in nanosatellite internet of things (IoT) connectivity, has closed a US$15 million Series A funding round. The round was led by Australian VC firms Main Sequence Ventures and Blue Sky Venture Capital and included Boeing HorizonX Ventures, Singtel Innov8 and Right Click Capital. It is globally the largest round announced to date for a tech startup using Space 2.0 for IoT. It is also the first investment outside the United States for Boeing HorizonX Ventures.


Australian biotech company launched with AU$7m investment to develop therapies for treating obesity

Cincera Therapeutics Pty Ltd (“Cincera”) has launched with an AU$7 million venture capital commitment from the Medical Research Commercialisation Fund (MRCF). The Company has been founded to develop new therapies to target conditions relating to an unhealthy Western diet, including serious and highly prevalent diseases associated with obesity. The company will initially focus on treatments for the emerging epidemic of a liver disease termed ‘NASH’ (non-alcoholic steatohepatitis).


SA university innovation to give back control to people with disability

A wireless hand controller designed in collaboration by researchers, students and experts from the University of South Australia, Flinders University and the Women’s and Children’s Hospital to give people with a range of conditions from cerebral palsy to arthritis more control, is about to be commercialised.


UniSA spearheads innovative Ventures in China

This week, the University of South Australia will become the first Australian university to have a technology transfer office in China’s most vibrant industrial development hub, Suzhou Industrial Park (SIP). 



UniSA spin-out Myriota

South Australian Internet of Things (IoT) company, Myriota, born out of advanced technologies developed at UniSA’s Institute for Telecommunications Research, has taken out the New Business award at this year’s South Australian Telstra Business Awards.



UniSA Leads information innovation

The University of South Australia’s enterprising approach to research, digital innovation and industry engagement has been acknowledged with a haul of category wins and a merit at the 2016 Australian Information Industry Association (AIIA) SA and NT iAwards.


Ferronova’s magnet cancer detection device draws investors

A NEW spin-out company will receive funding support from international partners to commercialise a locally-developed medical device that helps in easier detection of cancers using magnetic tracers. Read more at Adelaide Now.


Innovative local startups share in $100,000 Venture Catalyst grants

A gas turbine engine with the potential to be carbon neutral and keep homes running completely off the grid, and new software designed to streamline retail tenancies in shopping centres are the two local start-ups set to get a boost from this year’s UniSA Venture Catalyst grants. Read more at: Global Travel Media.


Myriota’s big plans for its smart blue box

AN Adelaide start-up that has developed satellite technology encapsulated within a low-cost, pocket-sized blue box, will aim to raise up to $20 million by the end of the year to launch its product globally. Read more at Adelaide Now.



UniSA Design Student Wins ITEK Commercial Award

Nirmal Menon was presented with the ITEK Commercial Student Award at the 2014 Smallacombe Damn Fine Design exhibition.The exhibition showcased the work of graduating students from UniSA’s Master of Design (Industrial Design) and Bachelor of Design (Industrial Design) programs.


New medical implant coating fights infection from within

University of South Australia researchers are developing new technology to reduce the risk of post-operative infection in biomedical implants such as hip and knee replacements.